In mice, the plasma concentrations of the appetite-stimulatory and autophagy-inhibitory factor
acyl-coenzyme A binding protein (ACBP, also called
diazepam-binding inhibitor,
DBI) acutely increase in response to
starvation, but also do so upon chronic
overnutrition leading to
obesity. Here, we show that knockout of Acbp/
Dbi in adipose tissue is sufficient to prevent high-fat diet-induced
weight gain in mice. We investigated ACBP/
DBI plasma concentrations in several patient cohorts to discover a similar dual pattern of regulation. In relatively healthy subjects, ACBP/
DBI concentrations independently correlated with body mass index (BMI) and age. The association between ACBP/
DBI and BMI was lost in subjects that underwent major
weight gain in the subsequent 3-9 years, as well as in advanced
cancer patients. Voluntary fasting,
undernutrition in the context of advanced
cancer, as well as
chemotherapy were associated with an increase in circulating ACBP/
DBI levels. Altogether, these results support the conclusion that ACBP/
DBI may play an important role in body mass homeostasis as well as in its failure.